Blood and Bone Marrow Transplant Clinical Trials and Research
Stanford's Cutting-Edge Research
The Blood and Marrow Transplant Program is a
National Cancer Institute grant recipient. There are a
limited number of Blood and Bone Marrow Transplant
Programs in the country with such support.
Following is some of the research that Blood and Marrow Transplant Program physicians have recently been involved with:
- Cellular Therapeutics – translational research investigating specific cell populations, such as regulatory T-cells, cytokine induced killer (CIK) cells, tumor vaccines and memory T-cells.
- Graft-vs.host disease – investigating novel approaches to the prevention and treatment of graft-vs.-host disease.
- Haploidentical hematopoietic (blood forming) cell transplantation.
- Pioneered novel TLI/ATG allogeneic preparative regimen, which reduces rates of graft-vs.-host disease and lowers transplant-related risks in select disease types.
Learn more about blood and bone marrow transplant clinical trials.
Trial Administration